Medpace Holdings, Inc. Gain (Loss) on Extinguishment of Debt
Medpace Holdings, Inc. (MEDP) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2019-02-26
- Medpace Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2018 was $0.00.
- Medpace Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2017 was $0.00.
- Medpace Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2016 was -$10.73M.
- Medpace Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2015 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2016-12-31 | -$10.73M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | |
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |